Press Resease

Genotyping Assay Market by Products & Services (Reagents & Kits, Genotyping Services, Instruments, and Bioinformatics), by Technology (PCR, Microarrays, Sequencing, Capillary Electrophoresis, MALDI-Tof MS, and Others), by Application (Pharmacogenomics, Diagnostics & Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), and by End-User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 01-Mar-2019 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-3874 Status : Published

Global genotyping assay market expected to generate around USD 46.9 billion by 2025, at a CAGR of around 21.8% between 2019 and 2025. Genotyping is a technology used to identify genetic variation in the genomic sequence or allelic genes of an individual by comparing it against the reference sequence.

Description

The report covers a forecast and an analysis of the genotyping assay market on a global and regional level. The study provides historical data from 2016 to 2018 along with forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the genotyping assay market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the genotyping assay market on a global and regional level.

In order to give the users of this report a comprehensive view of the genotyping assay market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Genotyping Assay Market

The report provides company market share analysis to give a broader overview of the key players in the genotyping assay market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research& development, regional expansion of major participants involved in the genotyping assay market on a global and regional basis.

The study provides a decisive view of the genotyping assay market by segmenting it based on products and services, technology, application, end-user, and region. Based on products and services, the market is segmented into genotyping services, reagents and kits, instruments and bioinformatics. Instruments are further segmented into sequencers and amplifiers and analyzers. Bioinformatics segment includes software and services. By technology, the market is segmented into microarrays, polymerase chain reaction (PCR), sequencing, capillary electrophoresis, matrix-assisted laser desorption/ionization-time of flight (MALDI-Tof) mass spectrometry, and others. Polymerase chain reaction (PCR) is further segmented into real-time PCR and digital PCR. Sequencing segment is further split into next-generation sequencing, pyrosequencing, and Sanger sequencing. Capillary electrophoresis technology segment is further split into amplified fragment length polymorphism (AFLP), restriction fragment length polymorphism (RFLP), and single-strand conformation polymorphism. Based on application, the market is split into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. Pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others form the end-user segment of the market.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global genotyping assay market include Thermo Fisher Scientific, Inc., Illumina, Inc., Roche Diagnostics Limited, Danaher Corporation, Qiagen N.V., Fluidigm Corporation, Agilent Technologies, Inc., GE Healthcare, Integrated DNA Technologies, Inc., Genewiz, Inc., Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Pacific Biosciences of California, Inc., and Eurofins Scientific.

This report segments the global genotyping assay market into:

Global Genotyping Assay Market: By Products and Services

  • Reagents and Kits
  • Genotyping Services
  • Instruments
    • Sequencers and Amplifiers
    • Analyzers
  • Bioinformatics
    • Software
    • Services

Global Genotyping Assay Market: By Technology

  • Polymerase Chain Reaction
    • Real-Time PCR
    • Digital PCR
  • Microarrays
  • Sequencing
    • Next-Generation Sequencing
    • Pyrosequencing
    • Sanger Sequencing
  • Capillary Electrophoresis
    • Amplified Fragment Length Polymorphism
    • Restriction Fragment Length Polymorphism
    • Single-Strand Conformation Polymorphism
  • Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-Tof) Mass Spectrometry
  • Others

Global Genotyping Assay Market: By Application

  • Pharmacogenomics
  • Diagnostics and Personalized Medicine
  • Animal Genetics
  • Agricultural Biotechnology 
  • Others

Global Genotyping Assay Market: By End-User

  • Pharmaceutical & Biopharmaceutical Companies
  • Diagnostic & Research Laboratories
  • Academic Institutes
  • Others

Global Genotyping Assay Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Genotyping Assay Market Revenue, 2016-2025(USD Billion)
    • 2.2. Global Genotyping Assay Market: Snapshot
  •  
  • Chapter 3. Genotyping Assay Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Genotyping Assay Market drivers: Impact analysis
      • 3.2.2. Increasing Prevalence of Genetic Disorders
      • 3.2.3. Technological Advancements
    • 3.3. Market Restraints
      • 3.3.1. High Cost of genotyping assay equipment and instruments
    • 3.4. Opportunities
      • 3.4.1. Increasing research and development activities in genotyping and sequencing
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Products and Services
      • 3.6.2. Market attractiveness analysis, by Technology
      • 3.6.3. Market attractiveness analysis, by Application
      • 3.6.4. Market attractiveness analysis, by End-user
      • 3.6.5. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Genotyping Assay Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Genotyping Assay Market: Company Market Share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Genotyping Assay Market - Products and Services Analysis
    • 5.1. Global Genotyping Assay Market: Products and Services Overview
      • 5.1.1. Global Genotyping Assay Market revenue share, by Products and Services, 2018 and 2025
    • 5.2. Reagents & Kits
      • 5.2.1. Global Genotyping Assay Market for Reagents & Kits, 2016-2025 (USD Billion)
    • 5.3. Genotyping Services
      • 5.3.1. Global Genotyping Assay Market for Genotyping Services, 2016-2025 (USD Billion)
    • 5.4. Instruments
      • 5.4.1. Global Genotyping Assay Market for Instruments, 2016-2025 (USD Billion)
    • 5.5. Bioinformatics
      • 5.5.1. Global Genotyping Assay Market for Bioinformatics, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Genotyping Assay Market - Technology Analysis
    • 6.1. Global Genotyping Assay Market: Technology overview
      • 6.1.1. Global Genotyping Assay Market revenue share, by Technology, 2018 and 2025
    • 6.2. Polymerase Chain Reaction (PCR)
      • 6.2.1. Global Genotyping Assay Market for Polymerase Chain Reaction, 2016-2025 (USD Billion)
    • 6.3. Microarrays
      • 6.3.1. Global Genotyping Assay Market for Microarrays, 2016-2025 (USD Billion)
    • 6.4. Sequencing
      • 6.4.1. Global Genotyping Assay Market for Sequencing, 2016-2025 (USD Billion)
    • 6.5. Capillary Electrophoresis
      • 6.5.1. Global Genotyping Assay Market for Capillary Electrophoresis, 2016-2025 (USD Billion)
    • 6.6. MALDI-Tof MS
      • 6.6.1. Global Genotyping Assay Market for MALDI-Tof MS, 2016-2025 (USD Billion)
    • 6.7. Others
      • 6.7.1. Global Genotyping Assay Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Genotyping Assay Market - Application Analysis
    • 7.1. Global Genotyping Assay Market: Application overview
      • 7.1.1. Global Genotyping Assay Market revenue share, by Application, 2018 and 2025
    • 7.2. Pharmacogenomics
      • 7.2.1. Global Genotyping Assay Market for Pharmacogenomics, 2016-2025 (USD Billion)
    • 7.3. Diagnostics & Personalized Medicine
      • 7.3.1. Global Genotyping Assay Market for Diagnostics & Personalized Medicine, 2016-2025 (USD Billion)
    • 7.4. Animal Genetics
      • 7.4.1. Global Genotyping Assay Market for Animal Genetics, 2016-2025 (USD Billion)
    • 7.5. Agricultural Biotechnology
      • 7.5.1. Global Genotyping Assay Market for Agricultural Biotechnology, 2016-2025 (USD Billion)
    • 7.6. Others
      • 7.6.1. Global Genotyping Assay Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global Genotyping Assay Market - End-user Analysis
    • 8.1. Global Genotyping Assay Market: End-user overview
      • 8.1.1. Global Genotyping Assay Market revenue share, by End-user, 2018 and 2025
    • 8.2. Pharmaceutical & Biopharmaceutical Companies
      • 8.2.1. Global Genotyping Assay Market for Pharmaceutical & Biopharmaceutical Companies, 2016-2025 (USD Billion)
    • 8.3. Diagnostic & Research Laboratories
      • 8.3.1. Global Genotyping Assay Market for Diagnostic & Research Laboratories, 2016-2025 (USD Billion)
    • 8.4. Academic Institutes
      • 8.4.1. Global Genotyping Assay Market for Academic Institutes, 2016-2025 (USD Billion)
    • 8.5. Others
      • 8.5.1. Global Genotyping Assay Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Global Genotyping Assay Market - Regional Analysis
    • 9.1. Global Genotyping Assay Market: Regional overview
      • 9.1.1. Global Genotyping Assay Market revenue share, by region, 2018 and 2025
    • 9.2. North America
      • 9.2.1. North America Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
      • 9.2.2. North America Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 9.2.3. North America Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
      • 9.2.4. North America Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
      • 9.2.5. The U.S.
        • 9.2.5.1. The U.S. Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
        • 9.2.5.2. The U.S. Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 9.2.5.3. The U.S. Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
        • 9.2.5.4. The U.S. Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
      • 9.2.6. Rest of North America
        • 9.2.6.1. Rest of North America Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
        • 9.2.6.2. Rest of North America Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 9.2.6.3. Rest of North America Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
        • 9.2.6.4. Rest of North America Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
    • 9.3. Europe
      • 9.3.1. Europe Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
      • 9.3.2. Europe Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 9.3.3. Europe Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
      • 9.3.4. Europe Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
      • 9.3.5. Germany
        • 9.3.5.1. Germany Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
        • 9.3.5.2. Germany Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 9.3.5.3. Germany Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
        • 9.3.5.4. Germany Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
      • 9.3.6. UK
        • 9.3.6.1. UK Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
        • 9.3.6.2. UK Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 9.3.6.3. UK Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
        • 9.3.6.4. UK Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
      • 9.3.7. France
        • 9.3.7.1. France Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
        • 9.3.7.2. France Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 9.3.7.3. France Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
        • 9.3.7.4. France Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
      • 9.3.8. Rest of Europe
        • 9.3.8.1. Rest of Europe Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
        • 9.3.8.2. Rest of Europe Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 9.3.8.3. Rest of Europe Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
        • 9.3.8.4. Rest of Europe Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
      • 9.4.2. Asia Pacific Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 9.4.3. Asia Pacific Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
      • 9.4.4. Asia Pacific Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
      • 9.4.5. China
        • 9.4.5.1. China Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
        • 9.4.5.2. China Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 9.4.5.3. China Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
        • 9.4.5.4. China Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
      • 9.4.6. Japan
        • 9.4.6.1. Japan Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
        • 9.4.6.2. Japan Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 9.4.6.3. Japan Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
        • 9.4.6.4. Japan Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
      • 9.4.7. India
        • 9.4.7.1. India Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
        • 9.4.7.2. India Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 9.4.7.3. India Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
        • 9.4.7.4. India Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
      • 9.4.8. Rest of Asia Pacific
        • 9.4.8.1. Rest of Asia Pacific Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
        • 9.4.8.2. Rest of Asia Pacific Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 9.4.8.3. Rest of Asia Pacific Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
        • 9.4.8.4. Rest of Asia Pacific Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
    • 9.5. Latin America
      • 9.5.1. Latin America Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
      • 9.5.2. Latin America Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 9.5.3. Latin America Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
      • 9.5.4. Latin America Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
      • 9.5.5. Brazil
        • 9.5.5.1. Brazil Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
        • 9.5.5.2. Brazil Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 9.5.5.3. Brazil Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
        • 9.5.5.4. Brazil Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
      • 9.5.6. Rest of Latin America
        • 9.5.6.1. Rest of Latin America Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
        • 9.5.6.2. Rest of Latin America Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 9.5.6.3. Rest of Latin America Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
        • 9.5.6.4. Rest of Latin America Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
    • 9.6. The Middle East and Africa
      • 9.6.1. The Middle East and Africa Genotyping Assay Market Revenue, by Products and Services, 2016-2025 (USD Billion)
      • 9.6.2. The Middle East and Africa Genotyping Assay Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 9.6.3. The Middle East and Africa Genotyping Assay Market Revenue, by Application, 2016-2025 (USD Billion)
      • 9.6.4. The Middle East and Africa Genotyping Assay Market revenue, by End-user, 2016-2025 (USD Billion)
  •  
  • Chapter 10. Company Profile
    • 10.1. Thermo Fisher Scientific, Inc.
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product Portfolio
      • 10.1.4. Business strategy
      • 10.1.5. Recent developments
    • 10.2. Illumina, Inc.
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product Portfolio
      • 10.2.4. Business strategy
      • 10.2.5. Recent developments
    • 10.3. Roche Diagnostics Limited
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product Portfolio
      • 10.3.4. Business strategy
      • 10.3.5. Recent developments
    • 10.4. Danaher Corporation
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product Portfolio
      • 10.4.4. Business strategy
      • 10.4.5. Recent developments
    • 10.5. Qiagen N.V.
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product Portfolio
      • 10.5.4. Business strategy
      • 10.5.5. Recent developments
    • 10.6. Fluidigm Corporation
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product Portfolio
      • 10.6.4. Business strategy
      • 10.6.5. Recent developments
    • 10.7. Agilent Technologies, Inc.
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product Portfolio
      • 10.7.4. Business strategy
      • 10.7.5. Recent developments
    • 10.8. GE Healthcare
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product Portfolio
      • 10.8.4. Business strategy
      • 10.8.5. Recent developments
    • 10.9. Integrated DNA Technologies, Inc.
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product Portfolio
      • 10.9.4. Business strategy
      • 10.9.5. Recent developments
    • 10.10. Genewiz, Inc.
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product Portfolio
      • 10.10.4. Business strategy
      • 10.10.5. Recent developments
    • 10.11. PerkinElmer, Inc.
      • 10.11.1. Overview
      • 10.11.2. Financials
      • 10.11.3. Product Portfolio
      • 10.11.4. Business strategy
      • 10.11.5. Recent developments
    • 10.12. Bio-Rad Laboratories, Inc.
      • 10.12.1. Overview
      • 10.12.2. Financials
      • 10.12.3. Product Portfolio
      • 10.12.4. Business strategy
      • 10.12.5. Recent developments
    • 10.13. Pacific Biosciences of California, Inc.
      • 10.13.1. Overview
      • 10.13.2. Financials
      • 10.13.3. Product Portfolio
      • 10.13.4. Business strategy
      • 10.13.5. Recent developments
    • 10.14. Eurofins Scientific
      • 10.14.1. Overview
      • 10.14.2. Financials
      • 10.14.3. Product Portfolio
      • 10.14.4. Business strategy
      • 10.14.5. Recent developments

Methodology

Free Analysis

Genotyping is a technology used to identify genetic variation in the genomic sequence or allelic genes of an individual by comparing it against the reference sequence. Genotyping helps to explore genetic variants including structural changes in DNA and single nucleotide polymorphism (SNPs).

The increasing prevalence of genetic disorders worldwide, decreasing cost of DNA sequencing, technological advancements in the field of genotyping, and growing use of genotyping for drug development are the major factors contributing toward the genotyping assay market globally. Additionally, the escalating demand for bioinformatics in drug discovery and data analysis, burgeoning popularity of personalized medicine, and increasing awareness about genotyping assay will further propel this market’s growth. Other factors anticipated to fuel the global genotyping assay market are increasing the need for rapid genotyping-based diagnostics tests and the rising number of increasing plant and animal genotyping research activities. However, the high cost of equipment used in genotyping assays may hamper the market growth in the future. Growing genotyping and sequencing research and development activities and massive demand for plant and animal genome analysis is to generate new growth opportunities for the genotyping assay market over the upcoming years.

Global Genotyping Assay Market

The global genotyping assay market segments are divided into products and services, technology, application, and end-user. Based on products and services, the market is segmented into genotyping services, reagents and kits, instruments and bioinformatics. Instruments are further segmented into sequencers and amplifiers and analyzers. Bioinformatics segment includes software and services.

By technology, the market is segmented into microarrays, polymerase chain reaction (PCR), sequencing, capillary electrophoresis, matrix-assisted laser desorption/ionization-time of flight (MALDI-Tof) mass spectrometry, and others. Polymerase chain reaction (PCR) is further segmented into real-time PCR and digital PCR. Sequencing segment is further split into next-generation sequencing, pyrosequencing and Sanger sequencing. Capillary electrophoresis technology segment is further split into amplified fragment length polymorphism (AFLP), restriction fragment length polymorphism (RFLP), and single-strand conformation polymorphism.

Based on application, the market is split into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. Pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others form the end-user segment of the market.

By region, North America led the global genotyping assay market in terms of revenue, with about 40% share, in 2018. Growing incidences of genetic disorders, technological advancements, the presence of major players, increasing the need for personalized medicines, and decreasing costs of DNA sequencing are some factors driving the North American genotyping assay market. The second largest region in the global genotyping assay market in 2018 was Europe, due to increasing investments made by private and public companies and the presence of robust healthcare infrastructure. The Asia Pacific genotyping assay market is estimated to show the highest CAGR over the forecast time period, owing to the flourishing pharmaceutical and biopharmaceutical industry, increasing geriatric population, rising health awareness, and growing research and development activities in developing nations, such as China, India etc.

Some key players of the global genotyping assay market include Thermo Fisher Scientific, Inc., Illumina, Inc., Roche Diagnostics Limited, Danaher Corporation, Qiagen N.V., Fluidigm Corporation, Agilent Technologies, Inc., GE Healthcare, Integrated DNA Technologies, Inc., Genewiz, Inc., Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Pacific Biosciences of California, Inc., and Eurofins Scientific.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com